Belgium· BE-AMP-SAM087132-00
Aldomet 250 mg
A methyldopa (levorotatory) product containing methyldopa, registered in Belgium by H.A.C. Pharma. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Methyldopa (levorotatory) is registered in 10 of 19 countries.
Countries holding a registration under ATC C02AB01 (methyldopa (levorotatory)), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Methyldopa (levorotatory) · ATC C02AB01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of methyldopa (levorotatory) costs, country by country.
Normalised to the WHO defined daily dose (1 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methyldopa (levorotatory) · price per daily dose (1 g)
USD · FX 28 Sept 2026
- IT Italy$0.42
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Methyldopa
- Manufacturer
- H.A.C. Pharma
- Country
- Belgium (BE)
- ATC code
- C02AB01
- ATC class
- Methyldopa (levorotatory)
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0100925
- be_apb0019091
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
182 interactions on record for methyldopa (levorotatory).
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methyldopa (levorotatory) · interactions on record
182 records
- 8 severe
- 95 moderate
- 10 minor
- 69 info
Most severe, free to view
- ProcarbazineL01XB01severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- OzanimodL04AA38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methyldopa (levorotatory) in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAldomet 250mg tabletsAspen Pharma Trading Ltd
- PolandDopegytDelfarma Sp. z o.o.
- NetherlandsL-Methyldopa Teva 125 mg, omhulde tablettenTeva Nederland B.V.
- United StatesMethyldopaRising Pharma Holdings, Inc.
- CanadaMETHYLDOPAAA PHARMA INC
- GermanyDopegytCheplapharm Arzneimittel Gmbh
- NorwayAldometAspen Global Health and Development
- FinlandMethyldopa MacureMacure Pharma ApS
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Aldometil
- Bulgaria · Допегит
- Cyprus · Dopamet, Methyldopa Remedica
- Czechia · Dopegyt
- Germany · Dopegyt, Methyldopa Stada
- Denmark · Methyldopa Macure
- Spain · Aldomet, Aldomet Forte
- Finland · Methyldopa Macure
- France · Aldomet
- United Kingdom (Northern Ireland) · Methyldopa, Methyldopa Accord-Uk
- Hungary · Dopegyt
- Italy · Aldomet
- Lithuania · Dopegyt
- Latvia · Dopegyt
- Malta · Methyldopa Remedica
- Netherlands · L-Methyldopa Teva, Methyldopa Cf
- Norway · Methyldopa Macure
- Poland · Dopegyt
- Portugal · Aldomet, Aldomet Forte
- Romania · Dopegyt
- Sweden · Methyldopa Macure
- Slovakia · Dopegyt
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4ef42cfd-8f49-4656-8291-71a3a59c38a2 GET /v1/drugs/4ef42cfd-8f49-4656-8291-71a3a59c38a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Aldomet 250 mg",
"name_fr": "Aldomet 250 mg",
"name_nl": "Aldomet 250 mg",
"amp_code": "SAM087132-00",
"strengths": [
"0.2000",
"1.1100"
],
"pack_count": 3,
"substances": [
"Methyldopa",
"Calcium Disodium Edetate",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Methyldopa (Levorotatory)",
"authorisation_numbers": [
"BE087132"
]
}See everything about methyldopa (levorotatory).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.